Biocompatibles International Overview
- Year Founded
-
1984
- Status
-
Acquired/Merged
- Employees
-
164
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
- Investments
-
5
Biocompatibles International General Information
Description
Manufacturer and seller of pharmaceuticals based in Farnham, United Kingdom. The company produces drug-eluting bead products that are used for the treatment of primary liver cancer, liver metastases from colorectal cancer, and other cancers.
Contact Information
Website
www.biocompatibles.co.ukCorporate Office
- Chapman House
- Farnham Business Park, Weydon Lane
- Farnham GU9 8QL
- England, United Kingdom
Corporate Office
- Chapman House
- Farnham Business Park, Weydon Lane
- Farnham GU9 8QL
- England, United Kingdom
Biocompatibles International Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Biocompatibles International Comparisons
Industry
Financing
Details
Biocompatibles International Competitors (20)
One of Biocompatibles International’s 20 competitors is Novartis, a Corporation company based in Basel, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Novartis | Corporation | Basel, Switzerland | ||||
| Gilead | Formerly VC-backed | Foster City, CA | ||||
| Merck & Co. | Corporation | Rahway, NJ | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Pfizer (Vienna) | Corporation | Vienna, Austria |
Biocompatibles International Patents
Biocompatibles International Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4333978-A1 | Distributing microparticles | Pending | 05-May-2021 | ||
| WO-2022234266-A1 | Distributing microparticles | Inactive | 05-May-2021 | ||
| US-20220090690-A1 | Multi-way connector | Inactive | 23-Sep-2020 | ||
| WO-2022064323-A1 | Multi-way connector | Inactive | 23-Sep-2020 | ||
| JP-2024147577-A | Cyclic actuation of ablation devices | Pending | 13-Mar-2020 | A61B18/1815 |
Biocompatibles International Signals
Biocompatibles International Acquisitions (5)
Biocompatibles International’s most recent deal was a Merger/Acquisition with BrachySciences for . The deal was made on 01-Aug-2008.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| BrachySciences | 01-Aug-2008 | Merger/Acquisition | Other Devices and Supplies | ||
| BTG International Germany | 04-Mar-2005 | Merger/Acquisition | Drug Delivery | ||
| Hydron (Therapeutic Devices) | 01-Mar-2000 | Merger/Acquisition | Therapeutic Devices | ||
| Evysio Medical Devices | 01-Jan-1996 | Merger/Acquisition | Medical Supplies | ||
| BioPolymerix | Merger/Acquisition | Other Devices and Supplies |
Biocompatibles International Exits (1)
Biocompatibles International’s most recent exit was on 04-Mar-2005 from BTG International Germany. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| BTG International Germany | 04-Mar-2005 | Completed |
|
Biocompatibles International FAQs
-
When was Biocompatibles International founded?
Biocompatibles International was founded in 1984.
-
Where is Biocompatibles International headquartered?
Biocompatibles International is headquartered in Farnham, United Kingdom.
-
What is the size of Biocompatibles International?
Biocompatibles International has 164 total employees.
-
What industry is Biocompatibles International in?
Biocompatibles International’s primary industry is Pharmaceuticals.
-
Is Biocompatibles International a private or public company?
Biocompatibles International is a Private company.
-
What is the current valuation of Biocompatibles International?
The current valuation of Biocompatibles International is .
-
What is Biocompatibles International’s current revenue?
The current revenue for Biocompatibles International is .
-
Who are Biocompatibles International’s competitors?
Novartis, Gilead, Merck & Co., Genentech, and Pfizer (Vienna) are some of the 20 competitors of Biocompatibles International.
-
When was Biocompatibles International acquired?
Biocompatibles International was acquired on 27-Jan-2011.
-
Who acquired Biocompatibles International?
Biocompatibles International was acquired by BTG.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process